-
Cholecystokinin octapeptide ammonium: Assay Guide
2026-09-30
Use CCK-8 ammonium as a sulfation-sensitive, receptor-directed probe for neurobehavioral, survival, immune, and cardiac assays. This practical guide connects concentration planning, CNS workflow design, formulation control, and troubleshooting to evidence from a classic electroacupuncture-tolerance study.
-
Diethylmaleate as a Causal Redox Probe
2026-09-30
Diethylmaleate is an intracellular glutathione modulator that helps researchers test causal links between redox imbalance, GST activity, and toxicant sensitivity. This guide translates insect-resistance findings into practical assay design, controls, and interpretation strategies.
-
Renalase–PMCA4b/cAMP Control of Aldosterone
2026-09-29
A 2026 study identifies a PMCA4b-dependent cAMP/PKA pathway through which renalase increases aldosterone production in NCI-H295R adrenocortical cells. The findings connect renalase to steroidogenic gene regulation without increasing cell proliferation, while also providing a mechanistic framework for studying renalase in primary aldosteronism.
-
Nonselective β-Blockers and HCT Engraftment
2026-09-29
The reference study shows that nonselective β-adrenergic blockade can impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition with metoprolol did not produce the same effect in the tested mouse and human settings. Its translational importance is the identification of post-transplant β-receptor selectivity, graft dose, and treatment context as variables that may influence engraftment and survival.
-
Pneumonectomy, SU5416, and Pulmonary Hypertension in Mice
2026-09-28
A 2024 short report tested whether pneumonectomy could replace hypoxia as the hemodynamic second hit in a mouse model combining vascular injury with SU5416 or monocrotaline pyrrole. In C57BL/6 mice, neither protocol produced severe, persistent pulmonary hypertension or greater pulmonary vascular remodeling than pneumonectomy alone, underscoring important species- and protocol-dependent limits.
-
Vitamin C Reduces Cochlear Cell Senescence via ROS/NF-κB
2026-09-28
A 2024 study found that Vitamin C improved several markers of D-galactose-induced senescence in HEI-OC1 cochlear cells, alongside reductions in reactive oxygen species and NF-κB activation. The results support a testable oxidative-stress mechanism for further age-related hearing loss research, while remaining preclinical and limited to a cell model.
-
Cytokine and Steroid Control of BIRC2 and BIRC3
2026-09-27
This study compares how inflammatory cytokines and glucocorticoids regulate BIRC2 and BIRC3 in pulmonary epithelial cell lines and primary bronchial epithelial cultures. Its central finding is a marked difference between the relatively stable BIRC2 protein and strongly inducible BIRC3, with implications for interpreting epithelial NF-κB signaling and steroid responses.
-
Resibufogenin Blocks NLRP3 in Atherosclerosis
2026-09-26
A 2025 study reports that resibufogenin reduced atherosclerotic plaque features in ApoE-/- mice and links these effects to inhibition of NLRP3 inflammasome assembly. Its combination of animal, cell-based, and binding analyses supports a mechanistic hypothesis while leaving questions about dose, safety, and clinical relevance for future work.
-
Firefly Luciferase mRNA: Assays and LNP Insights
2026-09-25
Use this bioluminescent reporter to compare mRNA delivery, translation, and cell-based assay conditions with a clear, quantifiable readout. Practical workflow guidance is paired with a careful look at how recent LNP vaccine research informs—without overpredicting—reporter assay design.
-
Annexin V-HF647/PI Apoptosis Kit in ESCC Research
2026-09-25
Learn how the Annexin V-HF647/PI Apoptosis Kit distinguishes phosphatidylserine exposure from loss of membrane integrity—and what those signals can and cannot reveal about cancer-cell death. An analysis of recent HOXC9–AKT/mTOR findings shows how to use apoptosis readouts without overinterpreting mechanism.
-
MDL 28170: Calpain Inhibitor Workflows
2026-09-24
Use MDL 28170 to test whether excessive cysteine-protease activity contributes to neuronal injury—not simply to label a result as calpain-specific. This workflow connects target engagement with BDNF/TrkB, synaptic, cell-survival, and behavioral readouts, while highlighting practical controls for interpreting partial rescue.
-
Pazopanib Hydrochloride: Read the Response, Not the Curve
2026-09-24
Pazopanib Hydrochloride (GW786034) is a multi-target inhibitor whose effects can look different depending on how a cancer assay defines response. Learn how to separate growth suppression from cell killing and design more interpretable preclinical studies.
-
Dacomitinib Workflows for ErbB Research
2026-09-23
Use Dacomitinib (PF-00299804) to connect ErbB receptor blockade with pathway, cell-cycle, and cell-death readouts in cancer models. This workflow also outlines a carefully bounded way to investigate mitochondrial ferroptosis biology without implying that Dacomitinib has been shown to regulate METTL17.
-
Epalrestat Neuroprotection in Parkinson’s Disease
2026-09-23
Jia et al. report that Epalrestat protects dopaminergic neurons in cellular and mouse Parkinson’s disease models by reducing oxidative stress and mitochondrial dysfunction. The study’s central innovation is evidence that Epalrestat directly engages KEAP1, promotes its degradation, and activates Nrf2 signaling, supporting further investigation of this aldose reductase inhibitor as a preclinical neuroprotection tool.
-
1-methyl Adenosine: From RNA Mark to Biomarker
2026-09-22
1-methyl Adenosine is more than a modified nucleoside standard: it can connect RNA turnover, cellular metabolism, and biomarker discovery. This guide explains how to interpret 1-methyl Ado measurements, resolve isomeric analytes, and design defensible cell-based assays.